|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/216 | |
| A61K 31/185 | |||
| A61K 31/192 | |||
| A61P 1/16 | |||
| A61P 13/12 | |||
| A61P 43/00 | |||
| G01N 33/68 |
| (11) | Number of the document | 3222275 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17154858.9 |
| Date of filing the European patent application | 2012-09-11 | |
| (97) | Date of publication of the European application | 2017-09-27 |
| (45) | Date of publication and mention of the grant of the patent | 2020-06-24 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261636256 P | 2012-04-20 | US |
| (72) |
SCHARSCHMIDT, Bruce, US
MOKHTARANI, Masoud, US
|
| (73) |
Immedica Pharma AB,
Norrtullsgatan 15, 113 29 Stockholm,
SE
|
| (54) | METHODS OF THERAPEUTIC MONITORING OF PHENYLACETIC ACID PRODRUGS |
| METHODS OF THERAPEUTIC MONITORING OF PHENYLACETIC ACID PRODRUGS |